1. Home
  2. RSKD vs CTMX Comparison

RSKD vs CTMX Comparison

Compare RSKD & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riskified Ltd.

RSKD

Riskified Ltd.

HOLD

Current Price

$4.45

Market Cap

661.3M

Sector

Technology

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$5.32

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RSKD
CTMX
Founded
2012
2008
Country
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
661.3M
596.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RSKD
CTMX
Price
$4.45
$5.32
Analyst Decision
Buy
Strong Buy
Analyst Count
8
7
Target Price
$5.91
$8.86
AVG Volume (30 Days)
573.6K
3.6M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.65
N/A
Revenue Next Year
$9.41
N/A
P/E Ratio
N/A
$22.00
Revenue Growth
N/A
N/A
52 Week Low
$3.94
$0.40
52 Week High
$5.86
$6.35

Technical Indicators

Market Signals
Indicator
RSKD
CTMX
Relative Strength Index (RSI) 47.57 50.40
Support Level $4.33 $5.20
Resistance Level $4.53 $5.65
Average True Range (ATR) 0.15 0.49
MACD 0.03 -0.10
Stochastic Oscillator 75.00 21.21

Price Performance

Historical Comparison
RSKD
CTMX

About RSKD Riskified Ltd.

Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: